Percentage of cytogenetically abnormal cells in pretransplant specimens per marker studied. Two patients had 2 abnormalities analyzed by molecular cytogenetics. One patient presented with both abnormalities in pretransplant marrow, and the other patient had only 1 of the 2 abnormalities detected in a sufficient number of cells to be considered present pretransplant.